- Home
- JUNS vs ANIK Comparison
JUNS vs ANIK Comparison
Compare JUNS & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JUNS
- ANIK
- Stock Information
- Founded
- JUNS 2015
- ANIK 1983
- Country
- JUNS United States
- ANIK United States
- Employees
- JUNS N/A
- ANIK N/A
- Industry
- JUNS
- ANIK Medical/Dental Instruments
- Sector
- JUNS
- ANIK Health Care
- Exchange
- JUNS NYSE
- ANIK Nasdaq
- Market Cap
- JUNS 281.4M
- ANIK 255.6M
- IPO Year
- JUNS 2024
- ANIK 1993
- Fundamental
- Price
- JUNS $4.40
- ANIK $16.07
- Analyst Decision
- JUNS
- ANIK Buy
- Analyst Count
- JUNS 0
- ANIK 2
- Target Price
- JUNS N/A
- ANIK $24.50
- AVG Volume (30 Days)
- JUNS 490.6K
- ANIK 76.3K
- Earning Date
- JUNS 02-11-2025
- ANIK 03-12-2025
- Dividend Yield
- JUNS N/A
- ANIK N/A
- EPS Growth
- JUNS N/A
- ANIK N/A
- EPS
- JUNS N/A
- ANIK N/A
- Revenue
- JUNS N/A
- ANIK $164,168,000.00
- Revenue This Year
- JUNS N/A
- ANIK N/A
- Revenue Next Year
- JUNS N/A
- ANIK N/A
- P/E Ratio
- JUNS N/A
- ANIK N/A
- Revenue Growth
- JUNS N/A
- ANIK 0.52
- 52 Week Low
- JUNS $3.86
- ANIK $15.40
- 52 Week High
- JUNS $19.51
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- JUNS N/A
- ANIK 43.88
- Support Level
- JUNS N/A
- ANIK $15.40
- Resistance Level
- JUNS N/A
- ANIK $16.22
- Average True Range (ATR)
- JUNS 0.00
- ANIK 0.60
- MACD
- JUNS 0.00
- ANIK 0.09
- Stochastic Oscillator
- JUNS 0.00
- ANIK 36.91
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.